Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.

Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia

Open access
Nakazawa, Kazu, Jeevakumar, Vivek, Nakao, Kazuhito · 2017 · npj Schizophrenia

Abstract

The N -methyl- d -aspartate receptor hypofunction is one of the most prevalent models of schizophrenia. For example, healthy subjects treated with uncompetitive N -methyl- d -aspartate receptor antagonists elicit positive, negative, and cognitive-like symptoms of schizophrenia. Patients with anti- N -methyl- d -aspartate receptor encephalitis, which is likely caused by autoantibody-mediated down-regulation of cell surface N -methyl- d -aspartate receptors, often experience psychiatric symptoms similar to schizophrenia initially. However, where and when N -methyl- d -aspartate receptor hypofunction occurs in the brain of schizophrenic patients is poorly understood. Here we review the findings from N -methyl- d- aspartate receptor antagonist and autoantibody models, postmortem studies on N -methyl- d -aspartate receptor subunits, as well as the global and cell-type-specific knockout mouse models of subunit GluN1. We compare various conditional GluN1 knockout mouse strains, focusing on the onset of N -methyl- d -aspartate receptor deletion and on the cortical cell-types. Based on these results, we hypothesize that N -methyl- d -aspartate receptor hypofunction initially occurs in cortical GABAergic neurons during early postnatal development. The resulting GABA neuron maturation deficit may cause reduction of intrinsic excitability and GABA release, leading to disinhibition of pyramidal neurons. The cortical disinhibition in turn could elicit glutamate spillover and subsequent homeostatic down regulation of N -methyl- d -aspartate receptor function in pyramidal neurons in prodromal stage. These two temporally-distinct N -methyl- d -aspartate receptor hypofunctions may be complimentary, as neither alone may not be able to fully explain the entire schizophrenia pathophysiology. Potential underlying mechanisms for N -methyl- d -aspartate receptor hypofunction in cortical GABA neurons are also discussed, based on studies of naturally-occurring N -methyl- d -aspartate receptor antagonists, neuregulin/ErbB4 signaling pathway, and theoretical analysis of excitatory/inhibitory balance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41537-016-0003-3

Cites

147 of 147 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Summary of schizophrenia-related phenotypes in various GluN1 mutant mice. GluN1 knockdown regardless of cell-types ("hypomorph mouse") presents several aspects of schizophrenia-related signs. GluN1 deletionin glutamatergic neurons (Emx1-cre KO and Nex-cre KO)during development both result in the phenotypes too severe to consider as schizophrenia-related signs. GluN1 deletion in forebrain principal neurons in adulthood (G35-3 cre-KO and αCaMKII cre-KO) appears to be sufficient to cause some neuropsychiatric signs, including E/I balance increase and cognitive dysfunction; however, insufficient to induce abnormalities of local GABA neurons seen in schizophrenia pathophysiology. Mouse strains with black arrows (top two strains) received genetic manipulation targeted to all the cells throughout the development. The manipulation in the mouse with blue arrows (bottom three strains) was largely restricted to the particular cell-types of forebrain principal neurons. Thick arrows in the left panel show the period of knockout occurring in the designated KO cell-type in the cortex. Hyphen denotes no data in the right Table. ROS reactive oxygen species. PPI, prepulse inhibition of startle reflex
Fig. 1 Summary of schizophrenia-related phenotypes in various GluN1 mutant mice. GluN1 knockdown regardless of cell-types ("hypomorph mouse") presents several aspects of schizophrenia-related signs. GluN1 deletionin glutamatergic neurons (Emx1-cre KO and Nex-cre KO)during development both result in the phenotypes too severe to consider as schizophrenia-related signs. GluN1 deletion in forebrain principal neurons in adulthood (G35-3 cre-KO and αCaMKII cre-KO) appears to be sufficient to cause some neuropsychiatric signs, including E/I balance increase and cognitive dysfunction; however, insufficient to induce abnormalities of local GABA neurons seen in schizophrenia pathophysiology. Mouse strains with black arrows (top two strains) received genetic manipulation targeted to all the cells throughout the development. The manipulation in the mouse with blue arrows (bottom three strains) was largely restricted to the particular cell-types of forebrain principal neurons. Thick arrows in the left panel show the period of knockout occurring in the designated KO cell-type in the cortex. Hyphen denotes no data in the right Table. ROS reactive oxygen species. PPI, prepulse inhibition of startle reflexCC BY · PubMed Central
Fig. 2 Summary of schizophrenia-related phenotypes in various GluN1 mutant mice, in which GluN1 knockout is targeted to GABA neurons. GluN1 deletion during the embryonic stage in migrating forebrain Dlx5/6-positive GABAergic cells lead to lethality(Dlx5/6 cre KO). In contrast, GluN1 deletion after postnatal 4 weeks in PV neurons (PV-cre KO) or after adolescence in Ppp1r2-positive GABA neurons (bottom strain) produce less phenotypes compared to the mutant mice that received GluN1 deletion in GABA neurons in early postnatal period (Ppp1r2 cre-KO starting from PND 7). Thus, it appears that early postnatal period, but not during the embryonic stage or after adolescence, is a critical period of GABAergic NMDAR hypofunction leading to schizophrenia. arrow shows the period of knockout occurring in the designated KO cell-type in the cortex. The level of intrinsic property maturation of neocortical fast-spiking neurons largely based on Refs. 68,69. Relative change in synaptic evoked NMDA component estimated from the data in Ref. 22 for hippocampal PV neurons and Ref. 65 for mPFC PV neurons. Hyphen denotes no data. The data of Dlx5/6 cre-KO mice is unpublished. ROS reactive oxygen species. PPI, prepulse inhibition of startle reflex
Fig. 2 Summary of schizophrenia-related phenotypes in various GluN1 mutant mice, in which GluN1 knockout is targeted to GABA neurons. GluN1 deletion during the embryonic stage in migrating forebrain Dlx5/6-positive GABAergic cells lead to lethality(Dlx5/6 cre KO). In contrast, GluN1 deletion after postnatal 4 weeks in PV neurons (PV-cre KO) or after adolescence in Ppp1r2-positive GABA neurons (bottom strain) produce less phenotypes compared to the mutant mice that received GluN1 deletion in GABA neurons in early postnatal period (Ppp1r2 cre-KO starting from PND 7). Thus, it appears that early postnatal period, but not during the embryonic stage or after adolescence, is a critical period of GABAergic NMDAR hypofunction leading to schizophrenia. arrow shows the period of knockout occurring in the designated KO cell-type in the cortex. The level of intrinsic property maturation of neocortical fast-spiking neurons largely based on Refs. 68,69. Relative change in synaptic evoked NMDA component estimated from the data in Ref. 22 for hippocampal PV neurons and Ref. 65 for mPFC PV neurons. Hyphen denotes no data. The data of Dlx5/6 cre-KO mice is unpublished. ROS reactive oxygen species. PPI, prepulse inhibition of startle reflexCC BY · PubMed Central
Fig. 3 Dual NMDAR hypofunction model for schizophrenia pathophysiology. Accumulating evidence from genetic and pharmacological studies lend support for spatially and temporally dissociated NMDAR hypofunction events in schizophrenia pathophysiology. The first NMDAR hypofunction occurs in cortical GABA neurons, including PV neurons, during early postnatal development, impairing the cortical circuitry maturation and leading to a variety of fast-spiking neuron-associated abnormalities, including gamma band synchrony deficits, oxidative stress increase, dopamine dysregulation, and disinhibition of pyramidal neurons. These abnormalities could contribute to the emergence of positive, negative and cognitive symptoms. Moreover, the E/I balance increase eventually elicits glutamate spillover during the prodromal period or later, which could produce a second NMDAR hypofunction in pyramidal neurons in response to low level but cumulative excitotoxicity. NMDAR hypofunction in pyramidal neurons may be responsible for spine density alteration of cortical pyramidal cells, which could also contribute to cognitive and negative symptoms as the disease progresses. Therefore, both types of NMDAR hypofunction may contribute to the schizophrenia pathophysiology. It is unclear when the first NMDAR hypofunction ends and the second hypofunction starts (shown by dotted lines). The cause of the first NMDAR hypofunction remains to be determined (but see text)
Fig. 3 Dual NMDAR hypofunction model for schizophrenia pathophysiology. Accumulating evidence from genetic and pharmacological studies lend support for spatially and temporally dissociated NMDAR hypofunction events in schizophrenia pathophysiology. The first NMDAR hypofunction occurs in cortical GABA neurons, including PV neurons, during early postnatal development, impairing the cortical circuitry maturation and leading to a variety of fast-spiking neuron-associated abnormalities, including gamma band synchrony deficits, oxidative stress increase, dopamine dysregulation, and disinhibition of pyramidal neurons. These abnormalities could contribute to the emergence of positive, negative and cognitive symptoms. Moreover, the E/I balance increase eventually elicits glutamate spillover during the prodromal period or later, which could produce a second NMDAR hypofunction in pyramidal neurons in response to low level but cumulative excitotoxicity. NMDAR hypofunction in pyramidal neurons may be responsible for spine density alteration of cortical pyramidal cells, which could also contribute to cognitive and negative symptoms as the disease progresses. Therefore, both types of NMDAR hypofunction may contribute to the schizophrenia pathophysiology. It is unclear when the first NMDAR hypofunction ends and the second hypofunction starts (shown by dotted lines). The cause of the first NMDAR hypofunction remains to be determined (but see text)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 147 references

Cited by

See all 110

Metadata

Authors
Nakazawa, K., Jeevakumar, V., & Nakao, K.
Affiliations
University of Alabama at Birmingham (US)
Corresponding author
Nakazawa, Kazu
Venue
npj Schizophrenia
Published
2017-02-03
Volume
3
Issue
1
Pages
7-7
ISSN
2334-265X (ISSN-L)
OpenAlex
W2580207551
Cited by
110
References
147
Citations by year
2026: 6 · 2025: 13 · 2024: 9 · 2023: 15 · 2022: 10 · 2021: 14 · 2020: 13 · 2019: 12 · 2018: 14 · 2017: 4
FWCI
9.65
Type
journal article
Language
en
Open access
Licence
Locations
  • Schizophrenia (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health
  • National Institute of Mental Health (R01MH110681, K22MH099164)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
NMDA receptor hypofunction, anti-NMDA receptor encephalitis, glutamate spillover, excitation-inhibition balance, postnatal development, prodromal schizophrenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia. https://app.cochat.ai/papers/10.1038/s41537-016-0003-3
The paper
Nakazawa, K., Jeevakumar, V., & Nakao, K. (2017). Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia. npj Schizophrenia. https://doi.org/10.1038/s41537-016-0003-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.